Adults ( n = 198 ) with moderate or severe acute sore throat and findings of pharyngitis on a Tonsillo-Pharyngitis Assessment ( TPA ) were randomly assigned to use either flurbiprofen 8.75 mg lozenges ( n = 101 ) or matching placebo lozenges ( n = 97 ) under double-blind conditions .